Cabaletta Bio (CABA) Assets Average (2019 - 2025)
Cabaletta Bio's quarterly Assets Average came in at $177.4 million in Q4 2025, down 8.89% year-on-year from $194.7 million in Q4 2024, and down 14.34% quarter-over-quarter from $207.1 million in Q3 2025.
Cabaletta Bio has reported Assets Average for 7 years, with the latest figure at $177.4 million in Q4 2025.
- For the quarter ending Q4 2025, Assets Average fell 8.89% year-over-year to $177.4 million; the trailing twelve-month figure through Dec 2025 stood at $177.4 million (down 8.89% YoY), and the FY2025 full-year result was $175.1 million, down 20.19% from the prior year.
- Assets Average for Q4 2025 stood at $177.4 million, down from $207.1 million in the prior quarter.
- The five-year high for Assets Average was $247.1 million in Q1 2024, with the low at $96.8 million in Q3 2022.
- Average Assets Average over 5 years is $158.5 million, with a median of $159.6 million recorded in 2023.
- Year-over-year, Assets Average jumped 124.17% in 2024 and slipped 29.13% in 2025.
- Tracing CABA's Assets Average over 5 years: stood at $124.5 million in 2021, then decreased by 16.2% to $104.3 million in 2022, then surged by 104.63% to $213.5 million in 2023, then retreated by 8.78% to $194.7 million in 2024, then fell by 8.89% to $177.4 million in 2025.
- The last three Assets Average figures came in at $177.4 million (Q4 2025), $207.1 million (Q3 2025), and $194.8 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13.04 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 33.42 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.72 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 331.70 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 40.89 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 26.06 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 26.03 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 40.71 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 5.05 Bn |
| 10 | Cabaletta Bio | 194.84 Mn | 61.24 Mn | - | 177.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 177.42 Mn |
| Sep 30, 2025 | 207.13 Mn |
| Jun 30, 2025 | 194.82 Mn |
| Mar 31, 2025 | 175.09 Mn |
| Dec 31, 2024 | 194.73 Mn |
| Sep 30, 2024 | 210.91 Mn |
| Jun 30, 2024 | 228.94 Mn |
| Mar 31, 2024 | 247.05 Mn |
| Dec 31, 2023 | 213.47 Mn |
| Sep 30, 2023 | 178.96 Mn |
| Jun 30, 2023 | 144.04 Mn |
| Mar 31, 2023 | 110.21 Mn |
| Dec 31, 2022 | 104.32 Mn |
| Sep 30, 2022 | 96.85 Mn |
| Jun 30, 2022 | 107.84 Mn |
| Mar 31, 2022 | 120.00 Mn |
| Dec 31, 2021 | 124.49 Mn |
| Sep 30, 2021 | 114.78 Mn |
| Jun 30, 2021 | 107.11 Mn |
| Mar 31, 2021 | 111.00 Mn |
| Dec 31, 2020 | 118.25 Mn |
| Sep 30, 2020 | 124.83 Mn |
| Jun 30, 2020 | 131.43 Mn |
| Mar 31, 2020 | 138.22 Mn |
| Dec 31, 2019 | 108.21 Mn |